Smiths Group PLC
21 March 2007
News Release
London, 21 March 2007
For immediate release
Smiths Detection wins US military contracts worth $38 million
SMITHS Detection, part of the global technology business Smiths Group, today
announces it has won five contracts worth a total of $38 million to supply
chemical detection and identification systems to the US military.
Stephen Phipson, Group Managing Director of Smiths Detection, said: 'Smiths
Detection has developed advanced technologies, often in partnership with
governments, which are helping to protect military forces world-wide from the
threat of lethal chemical agents.
'It is the application of those technologies in reliable products, which are
often used under the most extreme conditions, that has made Smiths Detection a
world leader in military detection systems and enabled us to win new and
follow-on contracts such as those announced today.'
The contracts announced today comprise:
• $19.25 million US Department of Defense contract for nerve and blister
agent detectors
Smiths Detection will supply the US Department of Defense with over 4,100
Improved Chemical Agent Monitor (ICAM) units. ICAM is a highly effective,
hand-held device that quickly monitors and confirms nerve and blister agent
contamination in personnel, vehicles, equipment and terrain. This new contract
follows a $9.5 million order for ICAM awarded in June 2006
• $14.2 million US Department of Defense contract for chemical detector
alarm units
Smiths Detection will provide GID-3 chemical agent detectors to the US
Department of Defense for its Automatic Chemical Agent Detector Alarm (ACADA)
program. The units can be carried, vehicle mounted or remotely deployed to warn
soldiers of the presence of chemical warfare agents. Since 1998 Smiths Detection
has supplied more than 35,000 ACADA (GID-3) units to the Department of Defense
• $4.5 million contracts to supply chemical identification equipment to
the US Air Force
Smiths Detection has received three contracts from the United States Air Force
Civil Engineering Support Agency worth $4.5 million. It is providing its
HazMatID portable chemical identifier and APD 2000 chemical detection system to
identify Toxic Industrial Chemicals, Toxic Industrial Materials and other
unknown liquid, solid or vapour threats.
ENDS
Smiths Group
Smiths is a global technology company, listed on the London Stock Exchange.
Smiths Group is a world leader in the practical application of advanced
technologies. Its products and services make the world safer, healthier and
more productive. Smiths Group has four divisions: Aerospace, Detection, Medical
and Specialty Engineering. It employs 32,000 people and has over 250 major
facilities in 50 countries. On 15 January 2007 Smiths Group announced the sale
of Smiths Aerospace to GE which remains subject to regulatory approvals. For
more information visit www.smiths.com
About Smiths Detection
Smiths Detection is part of the global technology business Smiths Group. It
offers advanced integrated security solutions for customers in civil and
military markets worldwide and is a leading technology developer and
manufacturer of sensors that detect and identify explosives, chemical and
biological agents, weapons, and contraband. Its advanced technology security
solutions also include Smiths Heimann x-ray imaging systems, millimeter-wave
technology and a specialist software supply business for the management of large
sensor and video surveillance networks. Separate business units focus on
related products for the life sciences, and food manufacturing industries. For
more information visit www.smithsdetection.com
Investor Relations Media
Russell Plumley Chris Fox
+44 (0)20 8457 8203 +44 (0)20 8457 8403
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.